These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22248240)

  • 1. Epidemiologic parameters and evaluation of control measure for 2009 novel influenza a (H1N1) in Xiamen, Fujian Province, China.
    Shen J; Niu J
    Virol J; 2012 Jan; 9():20. PubMed ID: 22248240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza.
    Tuite AR; Greer AL; Whelan M; Winter AL; Lee B; Yan P; Wu J; Moghadas S; Buckeridge D; Pourbohloul B; Fisman DN
    CMAJ; 2010 Feb; 182(2):131-6. PubMed ID: 19959592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R; Andrews N; Waight P; Malkani R; McCartney C; Ellis J; Miller E
    Vaccine; 2011 Mar; 29(14):2613-8. PubMed ID: 21292008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.
    Guzmán Herrador BR; Aavitsland P; Feiring B; Riise Bergsaker MA; Borgen K
    BMC Infect Dis; 2012 Mar; 12():63. PubMed ID: 22429643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
    Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection.
    Nelson CA; France EK; Shetterly SM; Glanz JM
    Pediatr Infect Dis J; 2011 Jul; 30(7):562-5. PubMed ID: 21248657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
    Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
    Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.
    Fielding JE; Grant KA; Garcia K; Kelly HA
    Emerg Infect Dis; 2011 Jul; 17(7):1181-7. PubMed ID: 21762570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.
    Steens A; Wijnans EG; Dieleman JP; Sturkenboom MC; van der Sande MA; van der Hoek W
    BMC Infect Dis; 2011 Jul; 11():196. PubMed ID: 21767348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
    Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
    Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    ;
    MMWR Recomm Rep; 2009 Aug; 58(RR-10):1-8. PubMed ID: 19713882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases.
    Barakat A; Ihazmad H; El Falaki F; Tempia S; Cherkaoui I; El Aouad R
    J Infect Dis; 2012 Dec; 206 Suppl 1(Suppl 1):S94-100. PubMed ID: 23169979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.
    Pelat C; Falchi A; Carrat F; Mosnier A; Bonmarin I; Turbelin C; Vaux S; van der Werf S; Cohen JM; Lina B; Blanchon T; Hanslik T
    PLoS One; 2011 May; 6(5):e19621. PubMed ID: 21573005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.